exRNAdisease

Entry Detail

---



General Information

Database ID: exR0759117 RNA Name: GSTP1 RNA Type: mRNA Chromosome: chr11 Starnd: + Coordinate: Start Site(bp): 67583742 End Site(bp): 67586656 External Links: ENSG00000084207

Disease Information

Disease Name: Glioblastoma Multiforme Disease Category: Cancers MeSH ID: D005909 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell

Expression Detail

GEO ID: GSE106804 Description: Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles Experimental Design: Cancer vs Control Case Disease Type: Glioblastoma Multiforme Case Disease SubType: NA Case Sample: Glioblastoma Multiforme Control Sample: Healthy Number of Case: 13 Number of Control: 6 Number of Samples: 19

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand ADAM17 chr2 9488486 9556732 - ACAD8 chr11 134253495 134265855 + AC008982.1 chr19 38817471 38840178 - ADCY7 chr16 50246137 50318135 + AL035078.4 chr11 31812391 32104665 + AL022238.4 chr22 40346529 40410054 + ACTB chr7 5527148 5563784 - ACSF2 chr17 50426158 50474845 + AC012184.2 chr16 70299194 70372582 + ADRM1 chr20 62302093 62308862 + ADCY3 chr2 24819169 24919839 - AC010323.1 chr19 8308283 8321379 - ACADVL chr17 7217125 7225266 + AC023055.1 chr12 55757275 55827546 - ABCF3 chr3 184186023 184194012 + ALDOA chr16 30064164 30070457 + ACTG1 chr17 81509971 81523847 - ADGRL2 chr1 81306160 81992436 + ABHD12 chr20 25294742 25390835 - ABRAXAS2 chr10 124801819 124836667 + AC004922.1 chr7 99325879 99394653 + ACTR1B chr2 97655939 97664044 - AL132780.3 chr14 22946270 22982258 - ADAR chr1 154582057 154628013 - AC010463.1 chr19 17267418 17282966 + ACOT13 chr6 24667035 24705065 + ACACA chr17 37084992 37406836 - ADSL chr22 40346500 40390463 + AC092073.1 chr19 34396315 34409364 + ALDH1L1 chr3 126103562 126197994 - miRNA targets: miRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa-miR-23a-3p chr19 13836595 13836615 - circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC009446.1 chr8 71675300 71702786 + AC016876.2 chr17 7581964 7584086 - AC026362.1 chr12 122975320 122982907 + AC139149.1 chr17 81514047 81527776 + AD000090.1 chr19 35557956 35581954 + AL138828.1 chr6 135991936 136225751 - Display:

Experiment Detail

GEO ID: NA Sample Source: NA Source Fraction: NA Platform: NA Method: NA Num of detected RNA Type: NA Num of detected RNAs of this Type: NA Sample treatment protocol: NA RNA Extract protocol: NA RNA library preparation protocol: NA

Reference

PMID: 29330365 Title: Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles. Author: Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL. Journal: Nat Commun. 2018 Jan 12;9(1):175. Description: Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.